To produce transgenic mice which express T cell receptors specific for (IRBP).
产生表达特异T细胞受体(IRBP)的转基因小鼠。
基本信息
- 批准号:7675985
- 负责人:
- 金额:$ 14.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-01 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferAntigensAreaAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityBackcrossingsBiomedical ResearchBreedingCell physiologyCellsCloningCommunitiesDevelopmentDiabetes MellitusDiseaseDisease modelEffector CellEpitopesExperimental Autoimmune EncephalomyelitisExperimental ModelsExploratory/Developmental GrantEyeFailureFluorescent DyesFosteringGenesGoalsImmuneImmune ToleranceImmune responseImmunizationIn VitroKnockout MiceLabelLeadLengthMediatingMethodsMicroinjectionsMicrotusModelingMononuclearMultiple SclerosisMusPancreasPeripheralPhotoreceptorsPopulationPosterior UveitisPre-Clinical ModelProcessProductionPropertyRIII MouseReceptor GeneResearchResearch PersonnelResearch Project GrantsRetinaRiskRoleSiteSourceSpecificitySystemT-Cell ReceptorT-Cell Receptor GenesT-LymphocyteTestingThymic epithelial cellThymus GlandTissuesTransfectionTransgenesTransgenic MiceTransgenic OrganismsUveitisVisionalpha-beta T-Cell Receptorautoimmune uveitisbeta Chain Antigen T Cell Receptordesignin vivointerstitial retinol-binding proteinintravital microscopymodel developmentmouse interstitial retinol-binding proteinmouse modelnovelpublic health relevancereceptorreceptor expressionresearch studysuccesszygote
项目摘要
DESCRIPTION (provided by applicant): Autoimmune posterior uveitis is a T cell mediated autoimmune disease characterized by mononuclear infiltrate into the retina and irreversible photoreceptor destruction. While the cause is unknown, experimental autoimmune uveitis (EAU) can be induced in mice through immunization with interphotoreceptor retinoid binding protein (IRBP). Numerous studies in the EAU field as well as other autoimmune disease models suggest that the primary cause of autoimmune disease is a failure of immune tolerance mechanisms. T cell receptor (TCR) transgenic mice have provided, and continue to provide, a wealth of important information on mechanisms of tolerance induction as well as mechanisms of autoimmune tissue destruction, particularly in the multiple sclerosis and diabetes fields. In this exploratory/developmental research grant application, the applicant proposes to develop TCR transgenic mice with specificity for IRBP as a new model for EAU. The applicant has successfully cloned full length cDNAs encoding the alpha and beta chains of the TCR from three IRBP specific T cell clones, and is in the process of cloning the receptor genes from two other T cell clones. In the first aim, the applicant will generate two lines of transgenic mice from two different T cell clones. In the second aim, the applicant will perform the initial characterization of the lines in order to establish them as useful models for EAU. These mice will be made available to the uveitis research community and create valuable new models for uveitis research. Studies using these mice may lead to new therapies for the treatment of uveitis.
PUBLIC HEALTH RELEVANCE: This project will generate new transgenic mouse models for autoimmune uveitis, a severe sight threatening autoimmune disease. Similar mouse models have been produced for multiple sclerosis and diabetes and have been responsible for dramatic advances in those fields. These mice will be made available to the research community and thus foster new research into cures or treatment for autoimmune uveitis.
描述(由申请人提供):自身免疫性后葡萄膜炎是一种T细胞介导的自身免疫性疾病,其特征为单核细胞浸润至视网膜和不可逆的感光细胞破坏。虽然原因不明,但可通过光感受器间类维生素A结合蛋白(IRBP)免疫小鼠诱导实验性自身免疫性葡萄膜炎(EAU)。EAU领域以及其他自身免疫性疾病模型中的许多研究表明,自身免疫性疾病的主要原因是免疫耐受机制的失败。T细胞受体(TCR)转基因小鼠已经并将继续提供大量关于耐受诱导机制以及自身免疫组织破坏机制的重要信息,特别是在多发性硬化症和糖尿病领域。在这项探索性/开发性研究资助申请中,申请人提议开发对IRBP具有特异性的TCR转基因小鼠,作为EAU的新模型。申请人已成功地从三个IRBP特异性T细胞克隆中克隆了编码TCR α和β链的全长cDNA,并且正在从另外两个T细胞克隆中克隆受体基因。在第一个目标中,申请人将从两个不同的T细胞克隆产生两个转基因小鼠系。在第二个目标中,申请人将对品系进行初步表征,以将其确立为EAU的有用模型。这些小鼠将提供给葡萄膜炎研究社区,并为葡萄膜炎研究创造有价值的新模型。使用这些小鼠的研究可能会导致治疗葡萄膜炎的新疗法。
公共卫生关系:该项目将产生新的转基因小鼠模型的自身免疫性葡萄膜炎,严重的视力威胁自身免疫性疾病。已经为多发性硬化症和糖尿病制作了类似的小鼠模型,并在这些领域取得了巨大进展。这些小鼠将提供给研究界,从而促进对自身免疫性葡萄膜炎的治愈或治疗的新研究。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Chylomicrons promote intestinal absorption and systemic dissemination of dietary antigen (ovalbumin) in mice.
- DOI:10.1371/journal.pone.0008442
- 发表时间:2009-12-24
- 期刊:
- 影响因子:3.7
- 作者:Wang Y;Ghoshal S;Ward M;de Villiers W;Woodward J;Eckhardt E
- 通讯作者:Eckhardt E
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jerold G Woodward其他文献
Unfolded Von Willebrand Factor Interacts with Protein S and Limits Its Anticoagulant Activity
- DOI:
10.1182/blood-2022-162612 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Martha MS Sim;Hammodah Alfar;Melissa Hollifield;Dominic W. Chung;Xiaoyun Fu;Meenakshi Banerjee;Chi Peng;Xian Li;Alice Thornton;James Z Porterfield;Jamie Sturgill;Gail A Sievert;Marietta Barton-Baxter;Kenneth S Campbell;Jerold G Woodward;José A. López;Sidney W Whiteheart;Beth A Garvy;Jeremy P Wood - 通讯作者:
Jeremy P Wood
Jerold G Woodward的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jerold G Woodward', 18)}}的其他基金
Chylomicrons promote intestinal absorption and systemic dissemination of dietary
乳糜微粒促进肠道吸收和膳食的全身传播
- 批准号:
8053458 - 财政年份:2010
- 资助金额:
$ 14.65万 - 项目类别:
To produce transgenic mice which express T cell receptors specific for (IRBP).
产生表达特异T细胞受体(IRBP)的转基因小鼠。
- 批准号:
7535963 - 财政年份:2008
- 资助金额:
$ 14.65万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 14.65万 - 项目类别:
Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别: